« Previous | Next » | All Messages |  DDSS Message Board Home |  Ignore Poster

Upcoming FDA decision on the approval of a small cap company's Depression drug

The FDA approval decision date for Labopharm (DDSS)'s Trazodone Contramid Once-Daily drug is coming up in July. If approved, this could become a breakthrough treatment for Depression. To find out what the chances are of the drug being approved, how the drug works, how is it different from existing depression drugs in the market, what is its sales potential if approved, read a FREE report on the upcoming FDA decision at:   http://www.newbiomedicine.com